AGT CLIA Kit

Produktnummer ABIN6200338

Produktdetails AGT CLIA Kit

Target: AGT (Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT))

Reaktivität: Maus

Nachweismethode: Chemiluminescent

Methodentyp: Competition ELISA

Detektionsbereich: 12.35 pg/mL - 1000 pg/mL

Untere Nachweisgrenze: 12.35 pg/mL

Applikation: ELISA

Verwendungszweck: Mouse Angiotensin I CLIA Kit is a Competitive CLIA Kit for use with Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Proben: Cell Culture Supernatant, Cell Lysate, Plasma, Serum, Tissue Homogenate

Analytische Methode: Quantitative

Sensitivität: < 4.72 pg/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: AGT (Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT))

Andere Bezeichnung: Angiotensin I (AGT Produkte)

Synonyme: ANHU CLIA Kit, SERPINA8 CLIA Kit, AI265500 CLIA Kit, AngI CLIA Kit, AngII CLIA Kit, Aogen CLIA Kit, Serpina8 CLIA Kit, ANRT CLIA Kit, Ang CLIA Kit, PAT CLIA Kit, wu:fb62f06 CLIA Kit, wu:fj87b02 CLIA Kit, zgc:111892 CLIA Kit, AGT CLIA Kit, angt CLIA Kit, ANGT CLIA Kit, angiotensinogen CLIA Kit, angiotensinogen (serpin peptidase inhibitor, clade A, member 8) CLIA Kit, AGT CLIA Kit, Agt CLIA Kit, agt CLIA Kit

Pathways: JAK-STAT Signalweg, ACE Inhibitor Pathway, EGFR Signaling Pathway, Peptide Hormone Metabolism, Regulation of Systemic Arterial Blood Pressure by Hormones, Regulation of Lipid Metabolism by PPARalpha, Protein targeting to Nucleus, Feeding Behaviour, Monocarboxylic Acid Catabolic Process, Dicarboxylic Acid Transport, Positive Regulation of Response to DNA Damage Stimulus, Regulation of long-term Neuronal Synaptic Plasticity